Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticles

Clinical and Vaccine Immunology

Volumn 16, Issue 3, 2009, Pages 408-413

  Tang, Shixing ^a   Moayeri, Mahtab ^b   Chen, Zhaochun ^b   Harma, Harri ^c   Zhao, Jiangqin ^a   Hu, Haijing ^b   Purcell, Robert H ^b   Leppla, Stephen H ^b   Hewlett, Indira K ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX TOXIN; EDEMA FACTOR; EUROPIUM; NANOPARTICLE; PROTECTIVE ANTIGEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTHRAX; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SPORE; BLOOD SAMPLING; CIRCULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; EDEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOASSAY; INTERMETHOD COMPARISON; LETHAL GENE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; ANIMALS; ANTHRAX; ANTIGENS, BACTERIAL; BACTERIAL TOXINS; EUROPIUM; FALSE POSITIVE REACTIONS; HUMANS; IMMUNOASSAY; MICE; NANOPARTICLES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 61949129575     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00412-08     Document Type: Article

References (32)

1. Abrami, L., S. Liu, P. Cosson, S. H. Leppla, and F. G. van der Goot. 2003. Anthrax toxin triggers endocytosis of its receptor via a lipid raft-mediated clathrin-dependent process. J. Cell Biol. 160:321-328.
2. Biagini, R. E., D. L. Sammons, J. P. Smith, B. A. MacKenzie, C. A. Striley, V. Semenova, E. Steward-Clark, K. Stamey, A. E. Freeman, C. P. Quinn, and J. E. Snawder. 2004. Comparison of a multiplexed fluorescent covalent microsphere immunoassay and an enzyme-linked immunosorbent assay for measurement of human immunoglobulin G antibodies to anthrax toxins. Clin. Diagn. Lab. Immunol. 11:50-55.
3. Biagini, R. E., D. L. Sammons, J. P. Smith, B. A. MacKenzie, C. A. Striley, J. E. Snawder, S. A. Robertson, and C. P. Quinn. 2006. Rapid, sensitive, and specific lateral-flow immunochromatographic device to measure anti-anthrax protective antigen immunoglobulin G in serum and whole blood. Clin. Vaccine Immunol. 13:541-546.
4. Chen, Z., M. Moayeri, Y. H. Zhou, S. Leppla, S. Emerson, A. Sebrell, F. Yu, J. Svitel, P. Schuck, M. St. Claire, and R. Purcell. 2006. Efficient neutralization of anthrax toxin by chimpanzee monoclonal antibodies against protective antigen. J. Infect. Dis. 193:625-633.
5. Harma, H., T. Soukka, S. Lonnberg, J. Paukkunen, P. Tarkkinen, and T. Lovgren. 2000. Zeptomole detection sensitivity of prostate-specific antigen in a rapid microtitre plate assay using time-resolved fluorescence. Luminescence 15:351-355.
6. Harma, H., T. Soukka, and T. Lovgren. 2001. Europium nanoparticles and time-resolved fluorescence for ultrasensitive detection of prostate-specific antigen. Clin. Chem. 47:561-568.
7. Hemmila, I., S. Dakubu, V. M. Mukkala, H. Siitari, and T. Lovgren. 1984. Europium as a label in time-resolved immunofluorometric assays. Anal. Biochem. 137:335-343.
8. Hu, H., Q. Sa, T. M. Koehler, A. I. Aronson, and D. Zhou. 2006. Inactivation of Bacillus anthracis spores in murine primary macrophages. Cell. Microbiol. 8:1634-1642.
9. Huhtinen, P., T. Soukka, T. Lovgren, and H. Harma. 2004. Immunoassay of total prostate-specific antigen using europium(III) nanoparticle labels and streptavidin-biotin technology. J. Immunol. Methods 294:111-122.
10. Jernigan, J. A., D. S. Stephens, D. A. Ashford, C. Omenaca, M. S. Topiel, M. Galbraith, M. Tapper, T. L. Fisk, S. Zaki, T. Popovic, R. F. Meyer, C. P. Quinn, S. A. Harper, S. K. Fridkin, J. J. Sejvar, C. W. Shepard, M. McConnell, J. Guarner, W. J. Shieh, J. M. Malecki, J. L. Gerberding, J. M. Hughes, and B. A. Perkins. 2001. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg. Infect. Dis. 7:933-944.
11. Leppla, S. 2006. Bacillus anthracis toxins, p. 323-347. In J. E. Alouf and M. R. Popoff (ed.), The comprehensive sourcebook of bacterial protein toxins. Academic Press, Burlington, MA.
12. Little, S. F., S. H. Leppla, and E. Cora. 1988. Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin. Infect. Immun. 56:1807-1813.
13. Little, S. F., J. M. Novak, J. R. Lowe, S. H. Leppla, Y. Singh, K. R. Klimpel, B. C. Lidgerding, and A. M. Friedlander. 1996. Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies. Microbiology 142(Pt 3):707-715.
14. Liu, S., and S. H. Leppla. 2003. Cell surface tumor endothelium marker 8 cytoplasmic tail-independent anthrax toxin binding, proteolytic processing, oligomer formation, and internalization. J. Biol. Chem. 278:5227-5234.
15. Mabry, R., K. Brasky, R. Geiger, R. Carrion, Jr., G. B. Hubbard, S. Leppla, J. L. Patterson, G. Georgiou, and B. L. Iverson. 2006. Detection of anthrax toxin in the serum of animals infected with Bacillus anthracis by using engineered immunoassays. Clin. Vaccine Immunol. 13:671-677.
16. Mabry, R., M. Rani, R. Geiger, G. B. Hubbard, R. Carrion, Jr., K. Brasky, J. L. Patterson, G. Georgiou, and B. L. Iverson. 2005. Passive protection against anthrax by using a high-affinity antitoxin antibody fragment lacking an Fc region. Infect. Immun. 73:8362-8368.
17. Moayeri, M., and S. H. Leppla. 2004. The roles of anthrax toxin in pathogenesis. Curr. Opin. Microbiol. 7:19-24.
18. Moayeri, M., J. F. Wiggins, and S. H. Leppla. 2007. Anthrax protective antigen cleavage and clearance from the blood of mice and rats. Infect. Immun. 75:5175-5184.
19. Nam, J. M., S. I. Stoeva, and C. A. Mirkin. 2004. Bio-bar-code-based DNA detection with PCR-like sensitivity. J. Am. Chem. Soc. 126:5932-5933.
20. Nam, J. M., C. S. Thaxton, and C. A. Mirkin. 2003. Nanoparticle-based bio-bar codes for the ultrasensitive detection of proteins. Science 301:1884-1886.
21. Park, S., and S. H. Leppla. 2000. Optimized production and purification of Bacillus anthracis lethal factor. Protein Expr. Purif. 18:293-302.
22. Pomerantsev, A. P., R. Sitaraman, C. R. Galloway, V. Kivovich, and S. H. Leppla. 2006. Genome engineering in Bacillus anthracis using Cre recombinase. Infect. Immun. 74:682-693.
23. Quinn, C. P., V. A. Semenova, C. M. Elie, S. Romero-Steiner, C. Greene, H. Li, K. Stamey, E. Steward-Clark, D. S. Schmidt, E. Mothershed, J. Pruckler, S. Schwartz, R. F. Benson, L. O. Helsel, P. F. Holder, S. E. Johnson, M. Kellum, T. Messmer, W. L. Thacker, L. Besser, B. D. Plikaytis, T. H. Taylor, Jr., A. E. Freeman, K. J. Wallace, P. Dull, J. Sejvar, E. Bruce, R. Moreno, A. Schuchat, J. R. Lingappa, S. K. Martin, J. Walls, M. Bronsdon, G. M. Carlone, M. Bajani-Ari, D. A. Ashford, D. S. Stephens, and B. A. Perkins. 2002. Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg. Infect. Dis. 8:1103-1110.
24. Rosi, N. L., and C. A. Mirkin. 2005. Nanostructures in biodiagnostics. Chem. Rev. 105:1547-1562.
25. Schaffer, P., H. Ionesco, A. Ryter, and G. Balassa. 1963. Sporulation of Bacillus subtilis: genetic and physiological study. Colloq. Int. CNRS 124:553-563.
26. Soukka, T., K. Antonen, H. Harma, A. M. Pelkkikangas, P. Huhtinen, and T. Lovgren. 2003. Highly sensitive immunoassay of free prostate-specific antigen in serum using europium(III) nanoparticle label technology. Clin. Chim. Acta 328:45-58.
27. Soukka, T., J. Paukkunen, H. Harma, S. Lonnberg, H. Lindroos, and T. Lovgren. 2001. Supersensitive time-resolved immunofluorometric assay of free prostate-specific antigen with nanoparticle label technology. Clin. Chem. 47:1269-1278.
28. Tang, S., J. Zhao, J. J. Storhoff, P. J. Norris, R. F. Little, R. Yarchoan, S. L. Stramer, T. Patno, M. Domanus, A. Dhar, C. A. Mirkin, and I. K. Hewlett. 2007. Nanoparticle-based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen. J. Acquir. Immune. Defic. Syndr. 46:231-237.
29. Turk, B. E. 2007. Manipulation of host signalling pathways by anthrax toxins. Biochem. J. 402:405-417.
30. Varughese, M., A. Chi, A. V. Teixeira, P. J. Nicholls, J. M. Keith, and S. H. Leppla. 1998. Internalization of a Bacillus anthracis protective antigen-c-Myc fusion protein mediated by cell surface anti-c-Myc antibodies. Mol. Med. 4:87-95.
31. Varughese, M., A. V. Teixeira, S. Liu, and S. H. Leppla. 1999. Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin. Infect. Immun. 67:1860-1865.
32. Williamson, E. D., I. Hodgson, N. J. Walker, A. W. Topping, M. G. Duchars, J. M. Mott, J. Estep, C. Lebutt, H. C. Flick-Smith, H. E. Jones, H. Li, and C. P. Quinn. 2005. Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax. Infect. Immun. 73:5978-5987.